Monday, May 30, 2022
HomeHealthFDA decides to restrict using Johnson & Johnson's COVID vaccine : NPR

FDA decides to restrict using Johnson & Johnson’s COVID vaccine : NPR


The US Meals and Drug Administration and the Facilities for Illness Management and Prevention confirmed a complete of 60 circumstances by which the J&J, Janssen vaccine resulted in uncommon and doubtlessly life-threatening blood clots.

Raul Arboleda/AFP through Getty Photos


conceal caption

toggle caption

Raul Arboleda/AFP through Getty Photos


The US Meals and Drug Administration and the Facilities for Illness Management and Prevention confirmed a complete of 60 circumstances by which the J&J, Janssen vaccine resulted in uncommon and doubtlessly life-threatening blood clots.

Raul Arboleda/AFP through Getty Photos

The U.S. Meals and Drug Administration is limiting using Johnson and Johnson’s Janssen COVID-19 vaccine as a final resort for adults who can not settle for a shot from one other producer.

Although the potential advantages of the vaccine outweigh the dangers, the FDA mentioned Thursday that it’s limiting using the Janssen vaccine. It is going to be restricted to people 18 and older and medically ineligible for one more accepted vaccine and to those that solely have entry to the J&J vaccine and wish one, in response to an FDA information launch.

Researchers with the FDA and Facilities for Illness Management and Prevention discovered that the vaccine resulted in 60 confirmed circumstances of thrombosis with thrombocytopenia syndrome. This results in uncommon however doubtlessly life-threatening blood clots, the FDA mentioned, one to 2 weeks after receiving the shot. And with a number of vaccines obtainable, the FDA determined to bench the J&J vaccine, solely for use when different choices are unavailable.

“Right now’s motion demonstrates the robustness of our security surveillance methods and our dedication to making sure that science and knowledge information our choices. We have been carefully monitoring the Janssen COVID-19 vaccine and prevalence of TTS following its administration and have used up to date info from our security surveillance methods to revise the EUA,” mentioned Peter Marks, director of the FDA’s Middle for Biologics Analysis and Analysis. “The company will proceed to observe the security of the Janssen COVID-19 Vaccine and all different vaccines, and as has been the case all through the pandemic, will totally consider new security info.”

Greater than 18.7 million doses of the J&J vaccine have been administered within the US because it was first accepted for emergency use, the Facilities for Illness Management and Prevention reported. Of which, a complete of 60 circumstances of TTS have been confirmed, together with 9 deaths.

Within the launch, the FDA mentioned, “The elements that put a person in danger for TTS following administration of Janssen COVID-19 Vaccine stay unknown.”

The Janssen vaccine rollout was first paused final spring after six circumstances of the uncommon blood clots had been reported. The pause was lifted days later and a warning was issued to healthcare suppliers to be looking out for sufferers with blood clots together with low blood platelets.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -
Google search engine

Most Popular

Recent Comments